Our results showed that PG2 alone or in combination with GM-CSF+IL4 also enhanced the production of functional mDCs in the breast, colon, ovarian, liver, gastric, and brain cancers (Figure 6F and Supplementary Figure S1). The gene discussed is IL4; the disease is brain cancer.